Cytotoxicity Test of Indonesian-made Pmma Acrylic Bone Cement on Fibroblasts and Osteoblasts

Main Article Content

Indri Lakhsmi Putri
Desrainy Inhardini Gunadiputri
David Sontani Perdanakusuma
Imaniar Fitri Aisyah
Pudji Lestari
Amalia Rasyida

Abstract

Introduction: Polymethyl methacrylate (PMMA) bone cement is widely used due to its affordability, durability, and suitability for large defects. However, Indonesia lacks PMMA products designed specifically for cranio-maxillofacial use. Institut Teknologi Sepuluh Nopember (ITS) has developed the first national PMMA bone cement for this purpose, using DmpT and DmoT as its catalysts. This study assesses the biocompatibility of ITS’s PMMA bone cement through cytotoxicity testing on fibroblast and osteoblast cells, and also the first to evaluate the cytotoxicity of DmoT-based PMMA bone cement, a cost-effective alternative to conventional DmpT-based products in Indonesia. Method: Cytotoxicity tests were conducted on BHK-21 fibroblast cells and hFOB osteoblast cells using MTT assay. The tests compared two types of ITS’s PMMA bone cement (PMMA-DmpT and PMMA-DmoT) to OGM® bone cement, a commercially established product. Results: ITS’s PMMA bone cement showed no toxicity to fibroblast or osteoblast cells, with cell viability levels similar to OGM® bone cement. Among the tested materials, OGM® bone cement had the highest cell viability, followed by PMMA-DmpT and PMMA-DmoT. Conclusion: PMMA bone cement developed by ITS using DmpT and DmoT catalysts is non-toxic to fibroblast and osteoblast cells.

Downloads

Download data is not yet available.

Article Details

How to Cite
Indri Lakhsmi Putri, Desrainy Inhardini Gunadiputri, David Sontani Perdanakusuma, Imaniar Fitri Aisyah, Pudji Lestari, & Amalia Rasyida. (2026). Cytotoxicity Test of Indonesian-made Pmma Acrylic Bone Cement on Fibroblasts and Osteoblasts. Malaysian Journal of Medicine and Health Sciences, 22(2). Retrieved from http://mjmhsojs.upm.edu.my/index.php/mjmhs/article/view/1545
Section
Original Articles

References

Fernandes da Silva AL, Borba AM, Simão NR, Pedro FLM, Borges AH, Miloro M. Customized Polymethyl Methacrylate Implants for the Reconstruction of Craniofacial Osseous Defects. Case Rep Surg. 2014;2014.

Chiang CC, Hsieh MK, Wang CY, Tuan WH, Lai PL. Cytotoxicity and cell response of preosteoblast in calcium sulfate-augmented PMMA bone cement. Biomedical Materials (Bristol). 2021;16(5).

Jiang HJ, Xu J, Qiu ZY, Ma XL, Zhang ZQ, Tan XX, et al. Mechanical properties and cytocompatibility improvement of vertebroplasty PMMA bone cements by incorporating mineralized collagen. Materials. 2015;8(5).

Salibian AA, Chiu ES. Principles of Prosthetics in Plastic Surgery. In: Chung KC, editor. Grabb and Smith’s Plastic Surgery. 8th ed. Philadelphia: Wolters Kluwer; 2020.

Marchac D, Greensmith A. Long-term experience with methylmethacrylate cranioplasty in craniofacial surgery. J Plast Reconstr Aesthet Surg [Internet]. 2008 Jul [cited 2024 Oct 9];61(7):744–52. Available from: https://pubmed.ncbi.nlm.nih.gov/18474454/

Bistolfi A, Ferracini R, Albanese C, Vernè E, Miola M. PMMA-based bone cements and the problem of joint arthroplasty infections: Status and new perspectives. Vol. 12, Materials. 2019.

Bastidas-Coral AP, Bakker AD, Kleverlaan CJ, Hogervorst JMA, Klein-Nulend J, Forouzanfar T. Polymethyl methacrylate does not adversely affect the osteogenic potential of human adipose stem cells or primary osteoblasts. J Biomed Mater Res B Appl Biomater. 2020;108(4).

Komatsu K, Hamajima K, Ozawa R, Kitajima H, Matsuura T, Ogawa T. Novel Tuning of PMMA Orthopedic Bone Cement Using TBB Initiator: Effect of Bone Cement Extracts on Bioactivity of Osteoblasts and Osteoclasts. Cells. 2022;11(24).

Sugino A, Ohtsuki C, Miyazaki T. In vivo response of bioactive PMMA-based bone cement modified with alkoxysilane and calcium acetate. J Biomater Appl. 2008;23(3).

International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. IARC Monogr Eval Carcinog Risks Hum. 2018;115.

International Organization for Standardization. ISO 10993-1:2018 - Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process. International Organization for Standardization. 2018;2018.

Chrisanti AAO. Analisis Pengaruh Variasi Temperatur Stirring dan Komposisi N,N-Dimethyl-o-toluidine terhadap Sifat Mekanik Acrylic Bone Cement untuk Cranioplasty. [Surabaya]: Institut Teknologi Sepuluh Nopember; 2023.

Standard 11266 I. International Organization of Standardization, ISO 10993-5:2009. Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity. 2009. 61010-1 © Iec:2001. 2014;2014.

International Organization for Standardization. ISO 10993-6 Biological evaluation of medical devices — Part 6: Tests for local effects after implantation. International Organization for Standardization. 2015;10406-1:20.

Park CM, Xian M. Use of Phosphorodithioate-Based Compounds as Hydrogen Sulfide Donors. Methods Enzymol. 2015 Jan 1;554:127–42.

Putri IL, Rachman A, Soesilawati P, Hakim L, Rantam FA, Perdanakusuma DS. Addition of adipose derived stem cell to beta tricalcium phosphate and human cancellous bone for craniofacial bone tissue engineering: An in vitro study. Malaysian Journal of Medicine and Health Sciences. 2020;16(4).

International Organization for Standardization. https://www.iso.org/obp/ui/en/#iso:std:iso:10993:-5:ed-3:v1:en. 2009. Biological evaluation of medical devices (ISO 10993-5:2009(E)).